Amnio Technology

Founded with a mission to enhance tissue donation and wound care, Amnio Technology focuses on developing and manufacturing amnion-derived technologies. Their core vision is to improve the regenerative potential and clinical application of unique tissues. The company offers a range of products, including chorion-free amniotic membranes and liquid products, under the PalinGen® brand. These products serve the unmet and underserved needs in wound care and orthopedics by providing biologic and physiologic properties that aid in tissue regeneration and protection.

Amnio Technology has made significant strides in the field of regenerative medicine, backed by years of research and development. The company is affiliated with leading experts in tissue engineering and regenerative therapies. Notable investors include key stakeholders in the biotech and medical device industries. Their innovative solutions have had a profound impact on improving patient outcomes in wound care and orthopedic applications, establishing Amnio Technology as a leader in the regenerative medicine market.